Diagnostic Medical Systems (FR:ALDMS) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Diagnostic Medical Systems (DMS Group) reported a 10% revenue increase in the first semester of 2024, with earnings of 22.9 million euros, signaling strong growth especially in their Radiology and Osteodensitometry activities. Despite a cyber attack, the company sustained growth with Radiology activity up 22% and Osteodensitometry up 14%. The firm’s gross margin also improved, rising three percentage points from the previous year.
For further insights into FR:ALDMS stock, check out TipRanks’ Stock Analysis page.